StockSelector.com
  Research, Select, & Monitor Tuesday, February 25, 2020 4:51:16 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Protalix BioTherapeutics Inc$3.64($.23)(5.94%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Protalix BioTherapeutics Inc has an overall rank of 1812 out of 6429 stocks based on 2 positive rankings and 0 negative rankings.

Positive Rankings
SSValue
The StockSelector Value for Protalix BioTherapeutics Inc is $124.43. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Protalix BioTherapeutics Inc is ranked 44.
PEGValue
Protalix BioTherapeutics Inc has a PEG Value of $53.70. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 1,375.24% in the next year. Among companies with a PEG Value above the current stock price, Protalix BioTherapeutics Inc is ranked 44.







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2020 StockSelector.com. All rights reserved.